Dr. Stephanie K. Fabbro, MD

Dr. Fabbro practices at Dermatologists of Southwest Ohio in Dayton, Ohio.

Dr. Fabbro's NPI, 1164798500, was assigned on March 29, 2012. Dr. Fabbro graduated from Northeast Ohio Medical University in 2012. Dr. Fabbro holds Ohio license 35128224.

Dr. Fabbro's primary practice is Dermatologists of Southwest Ohio, at 5300 Far Hills Ave, Dayton, OH 45429 in Montgomery County. The practice phone is (937) 433-7536.

Dr. Fabbro's primary practice is Dermatologists of Southwest Ohio in Dayton, Ohio. Dr. Fabbro is also affiliated with Mount Carmel East. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Fabbro to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fabbro practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Fabbro's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Fabbro is board certified in dermatology by the American Board of Dermatology. Dr. Fabbro is licensed in Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Fabbro treats.

CMS data shows 603 Medicare services from Dr. Fabbro across 10 procedure codes in 2024, for 175 Medicare patients. Medicare paid $31,759 for them. Every service was in an office.

CMS counts 175 Medicare patients who saw Dr. Fabbro in 2024. The largest group is 65 to 74, with 115 patients. 70% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fabbro's median patient age at 56, with 66% women.

In 2024, Dr. Fabbro wrote 426 Medicare Part D claims for 214 patients. 94% of them were for generic drugs. CMS names the drug for 299 of them, across 16 drugs with 11 or more claims each, at $8,988 in total drug cost. In 2023, CMS named 1,145 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Fabbro for performance year 2024, reported as part of a group. Dr. Fabbro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 57 procedures of melanoma (skin cancer) excision by Dr. Fabbro, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Fabbro, published from 2012 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Dermatology, Ethics, Medical and Practice Patterns, Physicians'. Dr. Fabbro has published most often in J Am Acad Dermatol. Dr. Fabbro's most frequent co-authors are Abraham Moris Korman, MD, Benjamin K. Stoff, MD and Jessica Amie Kaffenberger, MD.

CMS Open Payments shows 1,079 general payments to Dr. Fabbro from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Kyowa Kirin, Inc. paid the most, $25,892.

Dmand AI lists 8 awards for Dr. Fabbro, most recently Resident of Distinction Award in 2015.

Dr. Fabbro graduated from Northeast Ohio Medical University in 2012.

Dr. Fabbro is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.